We are live on
!
Find out more
AKRO
Akero Therapeutics
AKRO
AKRO
Delisted
AKRO was delisted on the 8th of December, 2025.
2 hedge funds and large institutions have $533K invested in Akero Therapeutics in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 258 closing their positions.
New
Increased
Maintained
Reduced
Closed
99% less funds holding
Funds holding: 265 → 2 (-263)
100% less capital invested
Capital invested by funds: $4.34B → $533K (-$4.34B)
100% less funds holding in top 10
Funds holding in top 10: 11 → 0 (-11)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 258
114.31% less ownership
Funds ownership: 114.34% → 0.02% (-114%)
Holders
2
Holders Change
-263
Holders Change %
-99.25%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-11
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
258
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
IA
IFP Advisors
Tampa,
Florida
|
+$478 |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$298M |
| 2 |
GA
General Atlantic
New York
|
-$272M |
| 3 |
BlackRock
New York
|
-$271M |
| 4 |
RI
RTW Investments
New York
|
-$260M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$215M |
